Management of polycythaemia vera: a critical review of current data.
about
Ruxolitinib in the treatment of polycythemia vera: patient selection and special considerationsExperience with ruxolitinib in the treatment of polycythaemia vera.Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.Erythrocytosis caused by giant chromophobe renal cell carcinoma: a case report indicating a 9-year misdiagnosis of polycythemia vera.
P2860
Management of polycythaemia vera: a critical review of current data.
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Management of polycythaemia vera: a critical review of current data.
@ast
Management of polycythaemia vera: a critical review of current data.
@en
type
label
Management of polycythaemia vera: a critical review of current data.
@ast
Management of polycythaemia vera: a critical review of current data.
@en
prefLabel
Management of polycythaemia vera: a critical review of current data.
@ast
Management of polycythaemia vera: a critical review of current data.
@en
P2093
P2860
P356
P1476
Management of polycythaemia vera: a critical review of current data.
@en
P2093
Bridget S Wilkins
Claire N Harrison
Mary F McMullin
P2860
P304
P356
10.1111/BJH.13812
P407
P577
2015-10-22T00:00:00Z